Showing results (541-550 of 591) with videos related to
Sort By:
Pageof 60
Journal of Dermatological Science|December 1, 1994
Type VII collagen DNA linkage analysis in a Japanese family with dominant dystrophic epidermolysis bullosaK Nomura, H Nakano, K Harada, et al.The Japanese Journal of Antibiotics|January 1, 1986
[Cefotiam concentration in exudate from suction drain of patients with breast cancer following intravenous administration]I Hashimoto, Y Sawada, T Nakamura, et al.The Japanese Journal of Antibiotics|January 1, 1986
Pharmacokinetics of cefotiam in the exudate from wounds of patients with breast cancer operated upon for radical mastectomyE Mizuta, Y Kaneko, H Nishindai, et al.The Journal of Investigative Dermatology|August 22, 2000
Compound heterozygosity for a point mutation and a deletion located at splice acceptor sites in the LAMB3 gene leads to generalized atrophic benign epidermolysis bullosaY Takizawa, Y Hiraoka, H Takahashi, et al.Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|June 1, 1995
[A case of ANCA negative Wegener's granulomatosis with pulmonary giant bulla showing high level of soluble ICAM-1]S Motoya, M Tsujisaki, Y Ibayashi, et al.The Japanese Journal of Antibiotics|April 1, 1981
[Clinical studies on 6059-S for acute peritonitis. Clinical effect and tissue concentration (author's transl)]I Hashimoto, Y Sawada, T Nakamura, et al.Nihon Geka Gakkai Zasshi|September 1, 1983
[Immunological evaluation of splenectomy in tumor-bearing mice]H Yamagishi, K Naito, Y Maeda, et al.The Japanese Journal of Antibiotics|August 1, 1981
[Clinical studies on tobramycin for infectious diseases following intravenous drip infusion (author's transl)]T Nakamura, I Hashimoto, Y Sawada, et al.The Japanese Journal of Antibiotics|June 1, 1985
[Cefotiam concentration in exudates from the drainage of patients with acute peritonitis following intravenous administration]H Nishindai, M Yoshimoto, Y Nakanishi, et al.The Japanese Journal of Antibiotics|April 1, 1981
[Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)]H Abe, S Hirasawa, E Bekki, et al.Pageof 60